BNP Paribas Financial Markets’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Buy |
70,709
+39,321
| +125% | +$937K | ﹤0.01% | 2745 |
|
|
2025
Q4 | $733K | Sell |
31,388
-4,292
| -12% | -$95.6K | ﹤0.01% | 3328 |
|
|
2025
Q3 | $703K | Sell |
35,680
-136,741
| -79% | -$2.81M | ﹤0.01% | 3375 |
|
|
2025
Q2 | $3.74M | Sell |
172,421
-11,664
| -6% | -$275K | ﹤0.01% | 2052 |
|
|
2025
Q1 | $4.46M | Buy |
184,085
+56,406
| +44% | +$1.27M | ﹤0.01% | 1889 |
|
|
2024
Q4 | $2.66M | Sell |
127,679
-25,571
| -17% | -$549K | ﹤0.01% | 2197 |
|
|
2024
Q3 | $3.05M | Buy |
153,250
+103,186
| +206% | +$1.91M | ﹤0.01% | 1796 |
|
|
2024
Q2 | $775K | Sell |
50,064
-39,903
| -44% | -$621K | ﹤0.01% | 2421 |
|
|
2024
Q1 | $1.43M | Sell |
89,967
-208,932
| -70% | -$3.15M | ﹤0.01% | 2261 |
|
|
2023
Q4 | $5.02M | Buy |
298,899
+117,970
| +65% | +$1.61M | 0.01% | 1401 |
|
|
2023
Q3 | $2.12M | Sell |
180,929
-15,099
| -8% | -$202K | ﹤0.01% | 1843 |
|
|
2023
Q2 | $2.63M | Sell |
196,028
-233,275
| -54% | -$3.36M | 0.01% | 1599 |
|
|
2023
Q1 | $7.12M | Buy |
429,303
+155,765
| +57% | +$2.57M | 0.02% | 1060 |
|
|
2022
Q4 | $5.09M | Sell |
273,538
-8,479
| -3% | -$131K | 0.01% | 1307 |
|
|
2022
Q3 | $3.62M | Buy |
282,017
+251,191
| +815% | +$2.98M | 0.01% | 1537 |
|
|
2022
Q2 | $216K | Buy |
30,826
+3,968
| +15% | +$29.1K | ﹤0.01% | 3050 |
|
|
2022
Q1 | $223K | Sell |
26,858
-27,143
| -50% | -$192K | ﹤0.01% | 3087 |
|
|
2021
Q4 | $366K | Buy |
54,001
+28,164
| +109% | +$185K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $137K | Buy |
25,837
+11,391
| +79% | +$62.3K | ﹤0.01% | 3167 |
|
|
2021
Q2 | $83.1K | Sell |
14,446
-15,100
| -51% | -$77.9K | ﹤0.01% | 3096 |
|
|
2021
Q1 | $136K | Buy |
29,546
+13,406
| +83% | +$53.3K | ﹤0.01% | 3210 |
|
|
2020
Q4 | $53.9K | Sell |
16,140
-9,589
| -37% | -$32.2K | ﹤0.01% | 3523 |
|
|
2020
Q3 | $76.4K | Buy |
25,729
+6,946
| +37% | +$27.2K | ﹤0.01% | 3256 |
|
|
2020
Q2 | $86.8K | Sell |
18,783
-62,624
| -77% | -$281K | ﹤0.01% | 2817 |
|
|
2020
Q1 | $313K | Buy |
81,407
+70,000
| +614% | +$287K | ﹤0.01% | 2617 |
|
|
2019
Q4 | $42.8K | Sell |
11,407
-3,887
| -25% | -$18.2K | ﹤0.01% | 3722 |
|
|
2019
Q3 | $81.2K | Buy |
15,294
+3,896
| +34% | +$20.8K | ﹤0.01% | 3229 |
|
|
2019
Q2 | $43.8K | Sell |
11,398
-8,644
| -43% | -$37.3K | ﹤0.01% | 3497 |
|
|
2019
Q1 | $102K | Buy |
+20,042
| New | +$58.9K | ﹤0.01% | 3113 |
|
|
2018
Q4 | – | Sell |
-3,128
| Closed | -$11.8K | – | 4349 |
|
|
2018
Q3 | $11.8K | Hold |
3,128
| – | – | ﹤0.01% | 3655 |
|
|
2018
Q2 | $9.76K | Sell |
3,128
-14,490
| -82% | -$44K | ﹤0.01% | 3791 |
|
|
2018
Q1 | $42.1K | Buy |
17,618
+2,761
| +19% | +$9.18K | ﹤0.01% | 3647 |
|
|
2017
Q4 | $58.1K | Buy |
14,857
+7,876
| +113% | +$26K | ﹤0.01% | 3583 |
|
|
2017
Q3 | $17.6K | Sell |
6,981
-517
| -7% | -$1.42K | ﹤0.01% | 3654 |
|
|
2017
Q2 | $20.7K | Buy |
+7,498
| New | +$15.6K | ﹤0.01% | 3644 |
|
|
2016
Q1 | – | Sell |
-15,206
| Closed | -$37.3K | – | 2749 |
|
|
2015
Q4 | $37.3K | Sell |
15,206
-23
| -0.2% | -$66 | ﹤0.01% | 3005 |
|
|
2015
Q3 | $45.7K | Buy |
15,229
+8,962
| +143% | +$38.7K | ﹤0.01% | 2929 |
|
|
2015
Q2 | $25.9K | Buy |
+6,267
| New | +$25K | ﹤0.01% | 2883 |
|
Other funds holding CPRX
VCM
DM
VPM